Fidelity Investments’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-513,612
| Closed | -$10.4M | – | 5198 |
|
|
2021
Q3 | $10.4M | Sell |
513,612
-105,100
| -17% | -$2.9M | ﹤0.01% | 2114 |
|
|
2021
Q2 | $23.1M | Hold |
618,712
| – | – | ﹤0.01% | 1786 |
|
|
2021
Q1 | $15.8M | Sell |
618,712
-103,800
| -14% | -$2.65M | ﹤0.01% | 1877 |
|
|
2020
Q4 | $15.9M | Hold |
722,512
| – | – | ﹤0.01% | 1805 |
|
|
2020
Q3 | $13M | Hold |
722,512
| – | – | ﹤0.01% | 1736 |
|
|
2020
Q2 | $18.4M | Hold |
722,512
| – | – | ﹤0.01% | 1586 |
|
|
2020
Q1 | $13.3M | Hold |
722,512
| – | – | ﹤0.01% | 1590 |
|
|
2019
Q4 | $15.9M | Buy |
722,512
+54,564
| +8% | +$1.1M | ﹤0.01% | 1679 |
|
|
2019
Q3 | $9.59M | Hold |
667,948
| – | – | ﹤0.01% | 1844 |
|
|
2019
Q2 | $10.5M | Sell |
667,948
-216,800
| -25% | -$2.95M | ﹤0.01% | 1861 |
|
|
2019
Q1 | $13M | Sell |
884,748
-218,200
| -20% | -$2.51M | ﹤0.01% | 1763 |
|
|
2018
Q4 | $11.8M | Sell |
1,102,948
-8,514
| -0.8% | -$112K | ﹤0.01% | 1748 |
|
|
2018
Q3 | $17M | Sell |
1,111,462
-332,449
| -23% | -$4.84M | ﹤0.01% | 1746 |
|
|
2018
Q2 | $17.7M | Sell |
1,443,911
-264,100
| -15% | -$3.32M | ﹤0.01% | 1764 |
|
|
2018
Q1 | $16.3M | Hold |
1,708,011
| – | – | ﹤0.01% | 1802 |
|
|
2017
Q4 | $15.4M | Buy |
1,708,011
+236,900
| +16% | +$1.74M | ﹤0.01% | 1815 |
|
|
2017
Q3 | $8.46M | Sell |
1,471,111
-878,599
| -37% | -$3.2M | ﹤0.01% | 2000 |
|
|
2017
Q2 | $7.45M | Sell |
2,349,710
-412,301
| -15% | -$1.3M | ﹤0.01% | 2048 |
|
|
2017
Q1 | $9.39M | Sell |
2,762,011
-600
| -0% | -$1.69K | ﹤0.01% | 1994 |
|
|
2016
Q4 | $7.96M | Sell |
2,762,611
-94,300
| -3% | -$335K | ﹤0.01% | 2047 |
|
|
2016
Q3 | $16.8M | Sell |
2,856,911
-252,005
| -8% | -$883K | ﹤0.01% | 1760 |
|
|
2016
Q2 | $9.33M | Buy |
3,108,916
+11,719
| +0.4% | +$48.1K | ﹤0.01% | 1996 |
|
|
2016
Q1 | $16.6M | Buy |
3,097,197
+8,230
| +0.3% | +$51.9K | ﹤0.01% | 1760 |
|
|
2015
Q4 | $36.7M | Buy |
3,088,967
+51
| +0% | +$583 | ﹤0.01% | 1382 |
|
|
2015
Q3 | $25.4M | Buy |
3,088,916
+2,400
| +0.1% | +$27.7K | ﹤0.01% | 1559 |
|
|
2015
Q2 | $43.1M | Buy |
3,086,516
+414,522
| +16% | +$7.6M | 0.01% | 1400 |
|
|
2015
Q1 | $64.2M | Buy |
2,671,994
+6,001
| +0.2% | +$135K | 0.01% | 1231 |
|
|
2014
Q4 | $43.9M | Buy |
2,665,993
+678
| +0% | +$7.82K | 0.01% | 1384 |
|
|
2014
Q3 | $33.9M | Buy |
2,665,315
+858
| +0% | +$12.9K | ﹤0.01% | 1497 |
|
|
2014
Q2 | $60.1M | Buy |
2,664,457
+62,054
| +2% | +$1.13M | 0.01% | 1267 |
|
|
2014
Q1 | $73.5M | Buy |
+2,602,403
| New | +$96.7M | 0.01% | 1139 |
|
Other funds holding DRNA
Fidelity Investments's DRNA Position: Q4 2021 in Review
Fidelity Investments sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 513,612 shares — an estimated $10.4M sold.
Fidelity Investments first reported a position in DRNA in Q1 2014 and held it in 31 quarters. The position peaked at $73.5M in Q1 2014. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.
- Fidelity Investments reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
- Fidelity Investments sold 513,612 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $10.4M.
- Fidelity Investments first reported a position in Dicerna Pharmaceuticals, Inc. in Q1 2014 and held it in 31 quarters.
- Fidelity Investments's Dicerna Pharmaceuticals, Inc. position peaked at $73.5M in Q1 2014.
- 1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.
Based on Fidelity Investments's 13F filing for Q4 2021, filed 14 Feb 2022.